Edwards Lifesciences CorporationEW

$87.36+0.68 (+0.78%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$51B
Large-cap
+140%
2016 — today
10-Year Price
+170%
2016 — today
52-Week Range
$72.65$88.58
Current $87.36· 92%

Edwards Lifesciences specializes in medical technologies for structural heart disease and critical care monitoring. Operating globally, its structural heart portfolio features transcatheter heart valve replacement systems and repair options for mitral and tricuspid pathologies, including PASCAL and Cardioband. Surgical solutions include the INSPIRIS aortic valve, KONECT RESILIA conduit, and HARPOON repair system. Its critical care division offers hemodynamic monitoring and the Acumen Hypotension Prediction Index.

Valuation in context

P/E ratio
46.5
Above average
Pricier than usual over the last 10 years
P/B ratio
4.9
Historically cheap
Historically cheap relative to the last 10 years
EV / EBITDA
34.5
Above average
Pricier than usual over the last 10 years
PEG ratio
6.8
Near historic high
Near historic highs — last 10 years
FCF Yield
2.2%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when EW is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.